Azithromycin versus standard care in patients with mild-tomoderate COVID-19 (ATOMIC2): an open-label, randomised tria
Créditos: Comité científico Covid
For Hospitalized Patients with COVID-19 Pneumonia, Tofacitinib May Be Beneficial
Compared with placebo, this Janus kinase inhibitor was associated with lower risk for death or respiratory failure in such patients. In patients hospitalized with COVID-19, excess inflammation generally underlies clinical progression. By reducing cytokine production, Janus kinase (Jak) inhibitors tamp down inflammation. Now, investigators report results of an industry-supported trial […]
Ischemic Stroke, Inflammation, and Endotheliopathy in COVID-19 Patients
Background and Purpose: Reports indicate an increased risk of ischemic stroke during coronavirus disease 2019 (COVID-19) infection. We aimed to identify patients with COVID-19 and ischemic stroke and explore markers of inflammation, hypercoagulability, and endotheliopathy, a structural and functional disturbance of the vascular endothelium due to a stressor. Methods: This […]
Most Patients Hospitalized With COVID-19 Have Lasting Symptoms
Three-quarters of patients hospitalized with coronavirus disease 2019 (COVID-19) still had at least 1 symptom 6 months after they became ill, according to recently published follow-up research. The study included 1733 patients who were hospitalized in Wuhan, China, and discharged between January and May 2020. Fatigue and ongoing muscle weakness […]
Outcomes for Patients Following Hospitalization for COVID-19
As of early March 2021, more than 2.5 million individuals worldwide have died from COVID-19, but many more millions have survived COVID-19 and experienced lasting sequelae. As many as half of patients who survive hospitalization for COVID-19 experience prolonged work absence, financial difficulty, or emotional effects, each of which may […]